Get started
Author

Sònia Sirisi

Observed names: S. Sirisi, Sirisi, Sònia, Sonia Sirisi, Sonia Sirisi Dolcet, SÒNIA SIRISI, Sònia Sirisi Dolcet, Sónia Sirisi
Observed institutions: Universitat Autònoma de Barcelona, Instituto de Salud Carlos III, Hospital de Sant Pau, Biomedical Research Networking Center on Neurodegenerative Diseases, Institut d'Investigació Biomédica de Bellvitge, Centre for Biomedical Network Research on Rare Diseases, Centro de Investigación Biomédica en Red, Institut de Recerca Sant Pau, Universitat de Barcelona
ORCID: 0000-0002-5366-7832
Observed ORCID: 0000-0002-5366-7832
OpenAlex ID: A5071737090
Synaptic oligomeric tau in Alzheimer’s disease — A potential culprit in the spread of tau pathology through the brain
2023 · Martí Colom-Cadena, Caitlin Davies, et al. · Neuron · 203
PDF
Mutant GlialCAM Causes Megalencephalic Leukoencephalopathy with Subcortical Cysts, Benign Familial Macrocephaly, and Macrocephaly with Retardation and Autism
2011 · Tania López-Hernández, Margreet C. Ridder, et al. · The American Journal of Human Genetics · 191
PDF
GlialCAM, a Protein Defective in a Leukodystrophy, Serves as a ClC-2 Cl− Channel Auxiliary Subunit
2012 · Elena Jeworutzki, Tania López-Hernández, et al. · Neuron · 145
PDF
The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders
2019 · Daniel Alcolea, Jordi Clarimón, et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 121
PDF
Disrupting MLC1 and GlialCAM and ClC-2 interactions in leukodystrophy entails glial chloride channel dysfunction
2014 · Maja B. Hoegg-Beiler, Sònia Sirisi, et al. · Nature Communications · 121
PDF
Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders
2020 · C. Delaby, D. Alcolea, et al. · Scientific Reports · 110
PDF
Molecular mechanisms of MLC1 and GLIALCAM mutations in megalencephalic leukoencephalopathy with subcortical cysts
2011 · Tania López-Hernández, Sònia Sirisi, et al. · Human Molecular Genetics · 102
Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: Altered energetic efficiency?
2012 · Cibely Cristine Fontes-Oliveira, Sílvia Busquets, et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 101
PDF
Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosis
2020 · Oriol Dols-Icardo, Víctor Montal, et al. · Neurology Neuroimmunology & Neuroinflammation · 88
PDF
Insights into MLC pathogenesis: GlialCAM is an MLC1 chaperone required for proper activation of volume-regulated anion currents
2013 · Xavier Capdevila-Nortes, Tania López-Hernández, et al. · Human Molecular Genetics · 61
Megalencephalic leukoencephalopathy with subcortical cysts protein 1 regulates glial surface localization of GLIALCAM from fish to humans
2014 · Sònia Sirisi, Mónica Folgueira, et al. · Human Molecular Genetics · 43
PDF
HDL-like-Mediated Cell Cholesterol Trafficking in the Central Nervous System and Alzheimer’s Disease Pathogenesis
2022 · Carla Borràs, Aina Mercer, et al. · International Journal of Molecular Sciences · 42
PDF
GlialCAM/MLC1 modulates LRRC8/VRAC currents in an indirect manner: Implications for megalencephalic leukoencephalopathy
2018 · Xabier Elorza-Vidal, Sònia Sirisi, et al. · Neurobiology of Disease · 38
APP dyshomeostasis in the pathogenesis of Alzheimer’s disease: implications for current drug targets
2024 · Sònia Sirisi, Érika Sánchez-Aced, et al. · Alzheimer s Research & Therapy · 35
Depolarization causes the formation of a ternary complex between GlialCAM, MLC1 and ClC-2 in astrocytes: implications in megalencephalic leukoencephalopathy
2017 · Sònia Sirisi, Xabier Elorza-Vidal, et al. · Human Molecular Genetics · 35
Megestrol acetate: Its impact on muscle protein metabolism supports its use in cancer cachexia
2010 · Sílvia Busquets, Roberto Serpe, et al. · Clinical Nutrition · 34
Functional Analyses of Mutations inHEPACAMCausing Megalencephalic Leukoencephalopathy
2014 · Tanit Arnedo, Tania López-Hernández, et al. · Human Mutation · 22
PDF
Formoterol and cancer muscle wasting in rats: Effects on muscle force and total physical activity
2011 · SÍLVIA BUSQUETS, MÍRIAM TOLEDO, et al. · Experimental and Therapeutic Medicine · 20
PDF
Synaptic oligomeric tau in Alzheimer’s disease – a potential culprit in the spread of tau pathology through the brain
2023 · Martí Colom-Cadena, Caitlin Davies, et al. · medRxiv · 19
PDF
Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration
2022 · Alba Cervantes González, David J. Irwin, et al. · Molecular Neurodegeneration · 19
PDF
Megalencephalic leukoencephalopathy with subcortical cysts: A personal biochemical retrospective
2017 · Raúl Estévez, Xabier Elorza-Vidal, et al. · European Journal of Medical Genetics · 18
PDF
Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies
2022 · David Reyes-Leiva, Oriol Dols-Icardo, et al. · Frontiers in Neurology · 16
PDF
The Down Alzheimer Barcelona Neuroimaging Initiative (DABNI) and its contributions to understanding Alzheimer's disease in Down syndrome: A decade of discovery
2025 · Laura Videla, Bessy Benejam, et al. · Alzheimer s & Dementia · 15
Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma
2022 · Natalia Valle-Tamayo, Rocío Pérez-González, et al. · Journal of Visualized Experiments · 15
VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome
2021 · Alberto Lleó, Maria Carmona-Iragui, et al. · Alzheimer s Research & Therapy · 15
PDF
Works count: 59
Citation count: 1,690
H-index: 19
I10-index: 28
Year
Topic
Type